Raleigh Capital Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
MIP
BIP
Raleigh Capital Management's SNY Position: Q2 2026 in Review
Raleigh Capital Management increased its Sanofi (SNY) stake by 12% in Q2 2026, buying an estimated $296K and bringing the position to 63,394 shares worth $2.7M. The position accounts for 0.86% of the portfolio, ranked #26.
Raleigh Capital Management first reported a position in SNY in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.74M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Raleigh Capital Management held 63,394 shares of Sanofi worth $2.7M as of Q2 2026.
- Raleigh Capital Management bought 6,624 Sanofi shares in Q2 2026, an estimated $296K.
- Sanofi made up 0.86% of Raleigh Capital Management's portfolio in Q2 2026, its #26 holding.
- Raleigh Capital Management first reported a position in Sanofi in Q4 2021 and has held it in 15 quarters since.
- Raleigh Capital Management's Sanofi position peaked at $2.74M in Q1 2026.
- 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.